Lucena, M.I et al.Daly, AKFernández-Checa, JCCubero Palero, Francisco Javier2024-03-182024-03-182024Lucena MI, Villanueva-Paz M, Alvarez-Alvarez I, Aithal GP, Björnsson ES, Cakan-Akdogan G, Cubero FJ, Esteves F, Falcon-Perez JM, Fromenty B, Garcia-Ruiz C, Grove JI, Konu O, Kranendonk M, Kullak-Ublick GA, Miranda JP, Remesal-Doblado A, Sancho-Bru P, Nelson L, Andrade RJ, Daly AK, Fernandez-Checa JC. Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet. Pharmacol Res. 2024 Feb;200:107046. doi: 10.1016/j.phrs.2023.107046. Epub 2023 Dec 28. PMID: 38159783.1043-6618https://doi.org/10.1016/j.phrs.2023.107046https://hdl.handle.net/20.500.14352/102300In the current article the aims for a constructive way forward in Drug-Induced Liver Injury (DILI) are to highlight the most important priorities in research and clinical science, therefore supporting a more informed, focused, and better funded future for European DILI research. This Roadmap aims to identify key challenges, define a shared vision across all stakeholders for the opportunities to overcome these challenges and propose a high-quality research program to achieve progress on the prediction, prevention, diagnosis and management of this condition and impact on healthcare practice in the field of DILI. This will involve 1. Creation of a database encompassing optimised case report form for prospectively identified DILI cases with well-characterised controls with competing diagnoses, biological samples, and imaging data; 2. Establishing of preclinical models to improve the assessment and prediction of hepatotoxicity in humans to guide future drug safety testing; 3. Emphasis on implementation science and 4. Enhanced collaboration between drug-developers, clinicians and regulatory scientists. This proposed operational framework will advance DILI research and may bring together basic, applied, translational and clinical research in DILI.engAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/journal article1096-1186https://www.sciencedirect.com/science/article/pii/S1043661823004024?via%3Dihubopen access612.0173D cultureArtificial intelligenceAtypical DILI phenotypesClinical trialsDILI predictionDILI risk stratificationDrug safetyExtracellular vesiclesFamilial studiesHealth careHumanized Mouse ModelsIdiosyncratic Drug-induced liver injuryIntegrative databaseIntegrative multi-scale dataNetworking; Organ-on-a-chipPharmacogenetic studiesPreclinical modelsPrognostic biomarkersRegulatoryZebrafish modelCiencias Biomédicas24 Ciencias de la Vida